Characterization of prescription opioid abuse in the United States: focus on route of administration.
about
Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrenceAssociations between prescription opioid injection and Hepatitis C virus among young injection drug users.Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women.Dynamic model of nonmedical opioid use trajectories and potential policy interventions.Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study.Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery.Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.The role of abuse-deterrent formulations in countering opioid misuse and abuse.Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations.Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.Effect of both preoperative andpostoperative cryoceutical treatment on hemostasis and postoperative pain following total knee arthroplasty.Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.Variability in prescription opioid intake and reinforcement amongst 129 substrains.Update on extended-release opioids in pain management.Small-Town America's Despair: Infected Substance Users Needing Outpatient Parenteral Therapy and Risk Stratification.Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
P2860
Q33938740-2B7F4EE4-6B9D-4215-8E87-AF6799326C6BQ34971493-49910EF4-A121-4C28-A646-A2F923C0F53CQ35586252-B1480757-4AF9-4136-B529-C04926B07512Q36389066-3278F550-EA70-4907-94EA-186810CD6A6AQ36619410-BD7C1BC3-E17E-43BA-86B9-D27B21A68C20Q38245151-AB7C83CD-61E2-4DBC-A15D-A97C4CEBA0ECQ38632934-2B2FDE5E-9ADE-4D00-AEC3-E022112A4688Q38643510-3AA52BFA-D10D-4918-AE34-6669383FE731Q38683620-A2652DBC-F4DE-4F13-83A8-B89A2E980DE3Q38799636-1219C578-2FBD-42B2-A829-A41787B07934Q38860656-38937937-2592-4691-982E-158645E3D28CQ41565144-EB2CB28E-F29B-4F69-ABEF-F4A51E57DC23Q41581475-E98AFA5D-F620-40AC-AA37-78C9C320946CQ42026736-8BA9F95C-2498-4D36-AE77-99D9BCEA43E2Q43062349-358C82F2-E623-49B0-9273-F97EDA272E4CQ44719170-4D20AF09-C87F-473E-9867-F9C0FEEC8937Q45037786-011903A5-A96F-4448-B587-5F965EABC46AQ50586416-A47A5500-EFD0-4180-BE33-5D5033D99523Q51285178-EEE706FB-0A30-4AD7-B1AA-72C87266F027
P2860
Characterization of prescription opioid abuse in the United States: focus on route of administration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Characterization of prescripti ...... us on route of administration.
@en
type
label
Characterization of prescripti ...... us on route of administration.
@en
prefLabel
Characterization of prescripti ...... us on route of administration.
@en
P2093
P2860
P1476
Characterization of prescripti ...... us on route of administration.
@en
P2093
John Coleman
John Peppin
Kenneth Kirsh
P2860
P304
P356
10.3109/15360288.2012.734905
P577
2012-12-01T00:00:00Z